Pure Global

Cancer Antigen 15-3 Enzyme Conjugate Reagent - India CDSCO Medical Device Registration

Cancer Antigen 15-3 Enzyme Conjugate Reagent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000078_f3b6919855730bbc9b4a932b43952047_4112c3df56b8399dfbe5c4b65e2b5e50. This device is marketed under the brand name AFP+CEA+PSA. The license holder is Tosoh India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Cancer Antigen 15-3 Enzyme Conjugate Reagent
UID: MFG/IVD/2021/000078_f3b6919855730bbc9b4a932b43952047_4112c3df56b8399dfbe5c4b65e2b5e50

Brand Name

AFP+CEA+PSA

License Holder

Tosoh India Pvt. Ltd.

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

For in-vitro diagnostic use only for quantitative determination of CA-15.3 in Human Serum by a Microplate Enzyme Immunoassay (AFP+CEA+PSA)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing